RayzeBio inc (DELISTED) (RYZB:DL)

62.49 0.00 (0.00%) USD  |  NASDAQ  |  Mar 06, 16:00
More

RayzeBio Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for RYZB:DL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2023. Upgrade now.
Date Value
March 02, 2024 --
February 28, 2024 --
February 26, 2024 --
December 31, 2023 --
Date Value
December 27, 2023 --
October 10, 2023 --
October 05, 2023 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

--
Minimum
Oct 05 2023
--
Maximum
Oct 05 2023
--
Average
--
Median
Oct 05 2023

Revenue Estimates for Current Fiscal Year Benchmarks

Bristol-Myers Squibb Co Upgrade
Karuna Therapeutics Inc (DELISTED) Upgrade
Ambrx Biopharma Inc (DELISTED) Upgrade
Pfizer Inc Upgrade
Mirati Therapeutics Inc (DELISTED) Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade